Cory Waters Email & Phone Number

Pleasanton, CA

Switzerland 🇨🇭, CH

Led cross-functional teams in the development of PCR-based in vitro diagnostic (IVD) products for personalized healthcare applications. Primary focus areas: Complex companion diagnostic tests (CDx) for Genomics and Oncology. - Managed seven projects, in association with pharmaceutical partners.- Recipient of Own It Award for streamlining development.

Franklin Lakes, New Jersey, US

Led up to three concurrent, 12-15 member, cross-functional teams for high complexity programs addressing improvements to systems consisting of flow cytometry analyzers, cell sorters, high-content bioimaging instruments, in vitro diagnostic (IVD) assays, software, and a sample preparation device in a regulated (FDA, ISO, cGMP) environment. Overcame severe.

Franklin Lakes, New Jersey, US

Built multi-disciplinary team from the ground up. Led team in - Design and development of novel disposable microfluidic cartridge prototype with on-board dried reagent diagnostic assay for new point-of-care diagnostic imaging cytometry platform in one year. - Development of new formulation matrix permitting dry-down of on-board reagents for developing.

Franklin Lakes, New Jersey, US

Led new business venture technical program for cell therapy technology development focused on transplantation, graft vs. host disease and autoimmune Type 1 diabetes applications. Built inter-divisional team and led translation of basic medical research findings from key opinion leaders' laboratories into a well-documented small-scale production process for.

Franklin Lakes, New Jersey, US

Rebuilt, restructured, and enhanced organizational effectiveness of a key product development group in an environment requiring on-time, on-budget delivery of multiple concurrent high complexity programs for the company's major IVD and life sciences research cell analyzers, cell sorters, sample preparation devices, diagnostic assays, and software. Met or.

Franklin Lakes, New Jersey, US

Re-envisioned and re-focused company's efforts to address a large market opportunity in sepsis. Led cross-functional, inter-divisional team in evaluation of biomarkers for early identification of patients at risk for sepsis. Successfully designed and completed clinical feasibility study with a key opinion leader, resulting in an issued US patent (7,465,555.

Evaluated new technology opportunities and managed intellectual property estate. Improved company's strategic position prior to sale by evaluating potential candidate technologies for in-licensing/partnering and advising outside legal counsel on scientific aspects of core technology patent language and claims defensibility, with estimated impact of $7M..

Built cell biology/immunology organizational capability for product characterization and applications development of lead product and product pipeline. Performed a variety of ancillary functions to meet company needs and further its objectives. Recruited, trained, and led team in characterization of Ontak for FDA Investigational New Drug (IND).

Responsible for cell biology-immunology start-up operations in new company. Evaluated early-stage research projects for scientific fitness and commercial potential, resulting in re-focusing of product development effort on recombinant fusion toxin proteins.Successfully generated cash for start-up with a Small Business Innovation Research (SBIR) grant for.

Ph.D., Biology

Education record

B.A. With Honors, Physics

Education record